![]() |
市場調查報告書
商品編碼
1784613
2021-2031年亞太地區抗菌手術縫線市場報告(範圍、細分、動態和競爭分析)Asia Pacific Antimicrobial Surgical Suture Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis |
亞太地區抗菌手術縫線市場規模預計將從 2023 年的 5,168 萬美元增至 2031 年的 1.2473 億美元。預計 2024 年至 2031 年期間該市場的複合年成長率為 11.7%。
執行摘要和亞太抗菌手術縫合線市場分析:
亞太地區抗菌手術縫線市場進一步細分為中國、日本、印度、澳洲、韓國和亞太其他地區。該地區是全球抗菌手術縫合線成長最快的市場。預計亞太地區將在預測期內實現最高成長。
受整形手術數量增加以及中國、印度等新興經濟體醫療旅遊需求成長等因素的影響,該地區抗菌手術縫線市場預計將實現成長。此外,預計在預測期內,研究數量的增加和醫療保健支出的激增也將推動市場成長。
亞太地區抗菌手術縫合線市場細分分析:
有助於得出抗菌手術縫線市場分析的關鍵部分是類型、原料、應用和最終用戶。
根據類型,亞太地區抗菌手術縫線市場分為三氯生抗菌縫線和氯己定抗菌縫線。 2023年,三氯生抗菌縫線佔據了較大的市場佔有率。
根據原料,亞太地區抗菌手術縫線市場細分為聚乳酸910抗菌縫線、聚卡普隆25和聚乙醇酸。聚乳酸910抗菌縫合線在2023年佔據了最大的市場佔有率。
根據應用,亞太地區抗菌手術縫線市場細分為心血管外科、一般外科、眼科、婦科、骨科、整形、獸醫、牙科等。心血管外科在2023年佔據了最大的市場。
依最終用戶分類,亞太地區抗菌手術縫線市場分為醫院、門診手術中心和其他類型。 2023年,醫院佔據了最大的市場。
亞太地區抗菌手術縫合線市場展望
皇家墨爾本理工大學材料創新與未來時尚中心是致力於開發新型智慧抗菌縫線以降低手術部位感染率的機構之一。該中心的縫合線產品採用在醫學影像過程中會發光的材料製成;這些縫合線有望取代網狀植入物,成為極具前景的替代方案。它們不僅具有卓越的抗菌性能,還能有效預防感染,並在體溫下接觸6小時後殺死99%的高抗藥性細菌,有助於監測患者康復進度。此外,由於能夠在術前影像中精確顯示網狀植入物的位置,因此可以顯著縮短手術時間並提高手術的準確性。
麻省理工學院的工程師發明了「智慧」縫合線,它不僅可以固定組織,還能感知發炎並輸送藥物。這種新型縫線由動物組織製成,類似古羅馬人發明的「羊腸線」。這些縫合線表面塗有水凝膠,可以與感測器、藥物,甚至釋放治療物質的細胞整合。對於因過度疤痕或發炎而需要接受結腸切除術的克隆氏症患者,這些縫合線尤其有益。麻省理工學院的智慧縫合線能夠固定組織,並將發炎識別為重新閉合的腸道功能異常的早期預警訊號。這些縫合線的水凝膠塗層透過由FDA批准的聚合物(例如PLA和PLGA)組成的微粒攜帶藥物,這些微粒也有助於控制藥物的釋放速率。這種方法也可用於輸送其他藥物,例如化療藥物或抗生素。因此,智慧抗菌手術縫合線的發展預計將在未來幾年為抗菌手術縫合線市場帶來新的成長趨勢。
亞太地區抗菌手術縫合線市場國家洞察
按國家分類,亞太地區抗菌手術縫線市場包括日本、中國、印度、韓國、澳洲和亞太其他地區。中國在2023年佔最大佔有率。
中國進行的整形手術數量僅次於美國,超過其他國家。一份報告顯示,2020年中國共進行了超過2,200萬例整形手術。這僅包括持證整形外科醫生進行的手術,由於中國有無證整形外科醫生,實際數量可能更高。中國對自我形象的觀念轉變、不斷成長的財富、科技進步以及對明星文化的執著推動了這一成長。在中國,在競爭激烈的中階職場中,美貌被視為一種優勢,因為求職者通常需要在申請時提交一張照片。
除了整形外科,骨科和一般外科也推動中國醫院縫線市場的發展。 2020年8月,北京海淀醫院正式引進骨科手術機器人,並於2020年5月正式投入使用。截至2021年8月底,該機器人手術已完成400多例。此骨科手術機器人能夠動態分析患者的解剖結構和脊椎-髖關節關係,並精準地依照計畫進行個人化手術規劃。
亞太地區抗菌手術縫線市場公司簡介
市場上一些主要的參與者包括 Advanced MedTech Solutions Pvt. Ltd.、Futura Surgicare Pvt Ltd(Dolphin Sutures)、Healthium Medtech Limited、Internacional Farmaceutica SA、強生公司、Meril Life Sciences Pvt Ltd 和 TI Medical 等。這些參與者正在採取各種策略,例如擴張、產品創新和併購,以向消費者提供創新產品並增加市場佔有率。
亞太地區抗菌手術縫合線市場研究方法:
本報告中的資料收集和分析遵循了以下方法:
二手資料研究:研究流程始於全面的二手資料研究,利用內部和外部資源收集每個市場的定性和定量資料。常用的二手資料研究來源包括但不限於:
公司網站、年度報告、財務報表、經紀商分析和投資者介紹。行業期刊及其他相關出版品。政府文件、統計資料庫和市場報告。針對在市場營運的公司的新聞文章、新聞稿和網路廣播。註:公司簡介部分所包含的所有財務資料均已標準化為美元。對於以其他貨幣報告的公司,數據已使用相應年份的相關匯率轉換為美元。
一手研究 Insight Partners 每年都會與行業利益相關者和專家進行大量的一手調查,以驗證其資料分析,並獲得寶貴的見解。這些研究訪談旨在:
驗證並完善二手資料研究的結果。提升分析團隊的專業知識和市場理解。深入了解市場規模、趨勢、成長模式、競爭動態和未來前景。一手資料研究透過電子郵件互動和電話訪談進行,涵蓋不同地區的各種市場、類別、細分市場和次細分市場。參與者通常包括:
產業利害關係人:副總裁、業務發展經理、市場情報經理和國家銷售經理外部專家:估值專家、研究分析師和具有行業專業知識的關鍵意見領袖
The Asia Pacific antimicrobial surgical suture market size is expected to reach US$ 124.73 million by 2031 from US$ 51.68 million in 2023. The market is estimated to record a CAGR of 11.7% from 2024-2031.
Executive Summary and Asia Pacific Antimicrobial Surgical Suture Market Analysis:
The Asia Pacific antimicrobial surgical suture market is further segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. This region is the fastest-growing market for antimicrobial surgical sutures in global scenarios. Asia Pacific is expected to witness the highest growth over the forecast period.
The antimicrobial surgical suture market in this region is expected to grow owing to factors such as rising plastic surgeries and increasing demand for medical tourism in emerging economies such as China and India. Moreover, the increase in the number of research studies and the surge in healthcare expenditure are anticipated to fuel the market growth during the forecast period.
Asia Pacific Antimicrobial Surgical Suture Market Segmentation Analysis:
Key segments that contributed to the derivation of the antimicrobial surgical suture market analysis are type, raw materials, application, and end user.
Based on type, the Asia Pacific antimicrobial surgical suture market is bifurcated into triclosan antimicrobial suture and chlorhexidine antimicrobial suture. The triclosan antimicrobial suture held a larger share of the market in 2023.
By raw materials, the Asia Pacific antimicrobial surgical suture market is segmented into polyglactin 910 antimicrobial suture, poliglecaprone 25, and polyglycolic acid. The polyglactin 910 antimicrobial suture segment held the largest share of the market in 2023.
By application, the Asia Pacific antimicrobial surgical suture market is segmented into cardiovascular surgery, general surgery, ophthalmic surgery, gynaecological surgery, orthopedic surgery, plastic surgery, veterinary surgery, dental surgery, and others. The cardiovascular surgery segment held the largest share of the market in 2023.
By end user, the Asia Pacific antimicrobial surgical suture market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the market in 2023.
Asia Pacific Antimicrobial Surgical Suture Market Outlook
The RMIT Centre for Materials Innovation and Future Fashion is one of the organizations focusing on developing new, smart antimicrobial sutures to reduce the prevalence of surgical site infections. The center's suture products are made from materials that glow during medical imaging procedures; these stitches have the potential to replace mesh implants as promising alternatives. They can be beneficial in monitoring patient recovery progress, in addition to their impressive antimicrobial properties, preventing infections and killing 99% of highly drug-resistant bacteria after 6 hours of contact at body temperature. It may also significantly reduce surgery duration and increase surgical accuracy in general through the ability to visualize mesh location accurately on preoperative imaging.
MIT engineers have created "smart" sutures that can not only hold tissues in place but also sense inflammation and deliver drugs. The new sutures are made from animal tissue, similar to the "catgut" sutures created by the ancient Romans. These sutures are coated with hydrogels that can be integrated with sensors, drugs, or even cells that release therapeutic substances. These sutures could be particularly beneficial for the treatment of Crohn's disease patients who need to undergo colectomy due to excessive scarring or inflammation. MIT's smart sutures hold the tissue in place and identify inflammation as an early warning sign indicating the improper functioning of the resealed intestines. The hydrogel coating of these sutures carries drugs through microparticles composed of FDA-approved polymers such as PLA and PLGA, which also aid in a controlled drug release rate. This approach could also be used to deliver other drugs, such as chemotherapy drugs or antibiotics. Therefore, developments in smart antimicrobial surgical sutures are expected to bring new growth trends in the antimicrobial surgical sutures market growth in the coming years.
Asia Pacific Antimicrobial Surgical Suture Market Country Insights
Based on country, the Asia Pacific antimicrobial surgical suture market comprises Japan, China, India, South Korea, Australia, and the Rest of Asia Pacific. China held the largest share in 2023.
China performs more plastic surgery operations than any country except America. According to a report, over 22 million plastic surgeries were performed in China in 2020. This includes only the procedures performed by licensed plastic surgeons, which is likely higher due to the presence of unlicensed plastic surgeons in China. China's changing attitudes toward self-image, growing wealth, technological advancements, and obsession with celebrity culture fuel this growth. In China, beauty is deemed an advantage in the competitive mid-level workplace because job applicants are often required to submit a photograph with their application.
Apart from Plastic surgeries, orthopedic and general surgeries are also propelling the market for hospital sutures in China. In August 2020, Beijing Haidian Hospital officially introduced orthopedic surgery robots in May 2020 and completed more than 400 robotic surgeries by the end of August 2021. The orthopedic surgical robot could dynamically analyze the patient's anatomy and the spine-hip relation and carry out individualized surgery planning precisely as planned.
Asia Pacific Antimicrobial Surgical Suture Market Company Profiles
Some of the key players operating in the market include Advanced MedTech Solutions Pvt. Ltd.; Futura Surgicare Pvt Ltd (Dolphin Sutures); Healthium Medtech Limited; Internacional Farmaceutica SA; Johnson & Johnson; Meril Life Sciences Pvt Ltd; and TI Medical among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
Asia Pacific Antimicrobial Surgical Suture Market Research Methodology :
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
Company websites , annual reports, financial statements, broker analyses, and investor presentations. Industry trade journals and other relevant publications. Government documents , statistical databases, and market reports. News articles , press releases, and webcasts specific to companies operating in the market. Note: All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research The Insight Partners' conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis, and gain valuable insights. These research interviews are designed to:
Validate and refine findings from secondary research. Enhance the expertise and market understanding of the analysis team. Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects. Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
Industry stakeholders : Vice Presidents, business development managers, market intelligence managers, and national sales managers External experts : Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise